Dr. Lal PathLabs completes acquisition of stake in SN Genelab Private Limited
Dr Lal Pathlabs · Healthcare Services
What the filing says
- Acquisition approved by the Board of Directors prior to completion
- Acquisition completed on October 01, 2026, as per agreement terms
- Prior disclosure made on September 24, 2026, as per SEBI regulations
Why it's rated notable: The filing confirms completion of the acquisition of a stake in SN Genelab Private Limited but states no amount, stake percentage or size, so the level is medium.
Original filing
Announcement under Regulation 30 (LODR)-Updates on Acquisition
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Electrical Equipment
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
More from Dr Lal Pathlabs
- Acquisition / mergerNotableDr Lal PathLabs completes acquisition of 80% stake in Sunshine Healthcare Limited, Ghana
Other acquisition / merger filings this fortnight
- Acquisition / mergerSwelect EnergySwelect Energy Systems to acquire 100% shares of Sushma Solar Energy Pvt Ltd
- Acquisition / mergerUgro Capital LtdUGRO Capital Ltd announces NCLT hearing date for amalgamation scheme with Profectus
- Acquisition / mergerCyient LtdCyient Limited announces Q2 and H1 FY27 financial results and corporate updates
- Acquisition / mergerSagilitySagility Limited reports Q2 FY27 financial results and declares interim dividend
- Acquisition / mergerShyam Metalics & Energy LtdShyam Sel and Power Ltd seeks NCLT approval for scheme to amalgamate Shree Venkateshwara Electrocast Pvt Ltd
- Acquisition / mergerPetronet LNG LtdPetronet LNG signs binding term sheet with Gruner Renewable for CBG JV
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.